Grow Well Smoke Free: A double-blind randomised placebo-controlled trial in pregnancy
Co-funded with the University of Newcastle’s Priority Research Centre Grow Up Well
more
![]() ![]()
2017
Project Grant
|
![]() ![]()
2017
Project Grant
|
![]() ![]()
2016
Project Grant
|
![]() ![]()
2016
Project Grant
|
![]() ![]()
2015
Project Grant
|
![]() ![]()
2015
Equipment Grant
|
![]() ![]()
2015
Project Grant
|
![]() ![]()
2015
Project Grant
|
![]() ![]()
2014
Project Grant
|
![]() ![]()
2013
Project Grant
|
![]() ![]()
2013
Project Grant
|
![]() ![]()
2013
Project Grant
|
![]() ![]()
2013
Project Grant
|
![]() ![]()
2011
Project Grant
|
![]() ![]()
2011
Project Grant
|
![]() ![]()
2011
Project Grant
|
![]() ![]()
2009
Project Grant
|
![]() ![]()
2009
Project Grant
|
![]() ![]()
2006
Project Grant
|
I am the Professor of Paediatrics at the University of Newcastle and a Senior Staff Specialist in Paediatric Respiratory Medicine and Sleep Medicine at the John Hunter Children’s Hospital. I am director of the Priority Research Centre GrowUpWell™ at the University of Newcastle in partnership with HMRI and Kaleidoscope. Our vision is to see an Australia where children grow up healthy, safe and well.
We have seen enormous advances in knowledge how diseases develop and progress. The challenge is now however to develop those discoveries into benefits that really matter to children. This is exactly what we at HMRI work on very successfully in collaboration with our community.
Professor Joerg Mattes is the Chair of Paediatrics and Child Health at the University of Newcastle, course coordinator for the Women, Children and Adolescent course in the Joint Medical program (MD) at the University of Newcastle and Clinical Director of the Paediatric Lung Function Service in the Northern NSW Child Health Network (Kaleidoscope).
Professor Mattes’ research looks at understanding how asthma, allergies and respiratory infections develop and how to prevent them from occurring in early life. As a trained clinician and basic science and clinical researcher, Professor Mattes believes that excellence in research and education promotes self-improving health care.
Professor Mattes was trained as a physician at the University Children's Hospital in Freiburg, Germany, from 1996 to 2005 which included a Research Fellowship at the John Curtin School of Medical Research, Australian National University Canberra from 1999 to 2001. In 2005, Professor Mattes earned a premier Research higher Degree doctorate qualification in Germany in Paediatric Immunology and Respiratory medicine and shortly after settled in Newcastle working as a Consultant in Paediatric Respiratory and Sleep Medicine across the entire Northern NSW Child Health Network but based at the John Hunter Children’s Hospital.
Professor Mattes has published more than 100 peer-reviewed research articles in top ranking journals and has brought in over $10 million in grant funding in the past 10 years. Using state-of-the-art experimental disease models, advanced laboratory and molecular techniques as well as infant and preschooler lung function testing, Professor Mattes is at the cutting edge of research into asthma during pregnancy and early life, allergies including peanut allergies in children and genetic susceptibility and regulation of infection and inflammation in the airways.
Professor Joerg Mattes
Grow Well Smoke Free: A double-blind randomised placebo-controlled trial in pregnancy
Co-funded with the University of Newcastle’s Priority Research Centre Grow Up Well
moreThe burden of asthma in children is unacceptably high. Asthma is the most common chronic childhood disease, affecting more than 10% of Australian children. Inhaled steroids are the most effective therapy for controlling asthma day to day, however, they do not prevent many acute attacks of asthma and many patients and carers are concerned about unwanted side effects, which reduces adherence to prescribed medications. Therefore, alternative strategies for managing asthma in children are urgently needed.
moreChildren born to mothers with asthma are three times more likely to develop asthma themselves than those with asthmatic fathers, which suggests that a risk factor extends beyond genetics. There is emerging evidence that bacteria in the infant’s gut can impact immune function and contribute to the types of immune responses that are seen in asthma.
moreFood allergies cause an enormous health burden to our community and peanut allergy is the most severe and persistent food allergy.
moreAsthma is the most common chronic childhood disease, affecting 10% of Australian children.
moreCurrently infants from the BLT cohort will be followed-up at birth, 6 weeks of age and 12 months of age.
moreAsthma is the most chronic childhood disease affecting 10% of children.
moreBronchiolitis is a very common life-threatening virus infection of the terminal airways affecting infants only.
moreDr Vanessa Murphy, Peter Gibson, Michael Hensley, Joerg Mattes
Clinical trial renamed to "The Breathing for Life Trial (BLT): A randomised trial of fractional exhaled nitric oxide based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health."
moreAsthma affects up to 10% of Australians and is the most common chronic disease complication during pregnancy.
moreOne third of the total annual asthma-related health care expenditures may be attributable to asthma related hospitalisations.
moreProfessor Joerg Mattes, Professor Peter Gibson, Professor M.Hensley, Associate Professor B.Whitehead, Dr Vanessa Murphy
Asthma prevelance has increased in many western countries over recent decades. Currently, 1 in 6 children in Australia are affected by the disease. Over this time, obesity rates have also increased, and obesity now effects around 10% of Australian children.
more